$91 Million
Joint Bookrunner
Initial Public Offering
September 2019
$173 Million
Joint Bookrunner
Follow-On
September 2019
$203 Million
Joint Bookrunner
Follow-On
September 2019
$225 Million
Joint Bookrunner
Follow-On
September 2019
$250M + $150M in Milestones
Exclusive Financial Advisor
Acquisition of Modis Therapeutics
September 2019
$350 Million
Co-Manager
Convertible Senior Notes
September 2019
UNDISCLOSED
Exclusive Financial Advisor
Merger with Neoleukin Therapeutics
August 2019
$69 Million
Joint Bookrunner
Follow-On
August 2019
$60 Million
Exclusive Placement Agent
Private Placement
July 2019
$209 Million
Joint Bookrunner
Initial Public Offering
July 2019
$74 Million
Joint Bookrunner
Initial Public Offering
July 2019
$575 Million
Joint Bookrunner
Follow-On
July 2019